These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31452019)

  • 1. Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan.
    Sakai K; Kuramoto J; Kojima A; Nishimura H; Kuwabara Y; Toda M; Kobayashi Y; Kikuchi S; Hirata Y; Mikami-Saito Y; Mikami S; Kyoyama H; Moriyama G; Gemma A; Uematsu K
    Int J Clin Oncol; 2019 Dec; 24(12):1549-1557. PubMed ID: 31452019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
    Park H; Dahlberg SE; Lydon CA; Araki T; Hatabu H; Rabin MS; Johnson BE; Nishino M
    Oncologist; 2019 Aug; 24(8):e749-e754. PubMed ID: 30696724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non-Small Cell Lung Cancer.
    Shin J; Keam B; Kim M; Park YS; Kim TM; Kim DW; Kim YW; Heo DS
    J Thorac Oncol; 2017 Mar; 12(3):520-528. PubMed ID: 27867003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of EGFR mutation status into M descriptor of new TNM classification influences survival curves in non-small cell lung cancer patients.
    Stanic K; Turnsek N; Vrankar M
    Radiol Oncol; 2019 Nov; 53(4):453-458. PubMed ID: 31747381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases.
    Nieder C; Hintz M; Oehlke O; Bilger A; Grosu AL
    Clin Transl Oncol; 2017 Sep; 19(9):1141-1146. PubMed ID: 28357633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer.
    Tufman A; Kahnert K; Kauffmann-Guerrero D; Manapov F; Milger K; Müller-Lisse U; Winter H; Huber RM; Schneider C
    Strahlenther Onkol; 2017 May; 193(5):392-401. PubMed ID: 28246699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of M descriptors of the 8th edition of TNM classification of lung cancer.
    Dias M; Antunes A; Campainha S; Conde S; Barroso A
    J Thorac Dis; 2017 Mar; 9(3):685-691. PubMed ID: 28449476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
    He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
    Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.
    Fong KM; Rosenthal A; Giroux DJ; Nishimura KK; Erasmus J; Lievens Y; Marino M; Marom EM; Putora PM; Singh N; Suárez F; Rami-Porta R; Detterbeck F; Eberhardt WEE; Asamura H;
    J Thorac Oncol; 2024 May; 19(5):786-802. PubMed ID: 38320664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.
    Ulivi P; Chiadini E; Dazzi C; Dubini A; Costantini M; Medri L; Puccetti M; Capelli L; Calistri D; Verlicchi A; Gamboni A; Papi M; Mariotti M; De Luigi N; Scarpi E; Bravaccini S; Turolla GM; Amadori D; Crinò L; Delmonte A
    Clin Lung Cancer; 2016 Sep; 17(5):384-390. PubMed ID: 26712101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
    Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
    Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry.
    Metzenmacher M; Griesinger F; Hummel HD; Elender C; Schäfer H; de Wit M; Kaiser U; Kern J; Jänicke M; Spring L; Zacharias S; Kaiser-Osterhues A; Groth A; Hipper A; Zaun G; Dörfel S; Güldenzoph B; Müller L; Uhlig J; Thomas M; Sebastian M; Eberhardt WEE;
    Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36180086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer.
    Hattori A; Takamochi K; Oh S; Suzuki K
    Jpn J Clin Oncol; 2019 Jan; 49(1):3-11. PubMed ID: 30277521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancer.
    Tan F; Bi N; Zhang H; Li R; Wang Z; Duan J; Jiang F; Feng D; Zhang R; Bai J; Cao J; Mao N; Liang K; Yin S; Shen Y; Feng F; Zhao J; Gao Y; Mao Y; Xue Q; Gao S; He J
    Lung Cancer; 2022 Aug; 170():98-104. PubMed ID: 35749952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Driven Gene in Patients with Lung Squamous Cell Carcinoma: 
Analysis of Clinicopathologic Characteristics and Prognosis].
    Zhang T; Li J
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):648-652. PubMed ID: 27760592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases.
    Wang J; Liu Z; Pang Q; Zhang T; Chen X; Er P; Wang Y; Wang P; Wang J
    BMC Cancer; 2020 Sep; 20(1):837. PubMed ID: 32883221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
    Eberhardt WE; Mitchell A; Crowley J; Kondo H; Kim YT; Turrisi A; Goldstraw P; Rami-Porta R;
    J Thorac Oncol; 2015 Nov; 10(11):1515-22. PubMed ID: 26536193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer.
    Kandathil A; Kay FU; Butt YM; Wachsmann JW; Subramaniam RM
    Radiographics; 2018; 38(7):2134-2149. PubMed ID: 30422775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of EGFR Mutation and ALK Translocation on Recurrence Pattern After Definitive Chemoradiotherapy for Inoperable Stage III Non-squamous Non-small-cell Lung Cancer.
    Nakamura M; Kageyama SI; Niho S; Okumura M; Hojo H; Motegi A; Nakamura N; Zenda S; Yoh K; Goto K; Akimoto T
    Clin Lung Cancer; 2019 May; 20(3):e256-e264. PubMed ID: 30926356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.
    Takahashi T; Sonobe M; Kobayashi M; Yoshizawa A; Menju T; Nakayama E; Mino N; Iwakiri S; Sato K; Miyahara R; Okubo K; Manabe T; Date H
    Ann Surg Oncol; 2010 Mar; 17(3):889-97. PubMed ID: 20183914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.